AMERICAN BIO MEDICA CORP Aktie - Fundamentalanalyse - Dividendenrendite KGV

AMERICAN BIO MEDICA CORP (ISIN: US0246001087, WKN: 912562) Kursdatum: 15.06.2018 Kurs: 0,100 USD
Beschreibung Daten
Symbol ABMC
Marktkapitalisierung 2.600.000,00 USD
Land Vereinigte Staaten von Amerika
Indizes NASDAQ Comp.
Sektor Biotechnologie
Rohdaten nach US GAAP in Millionen USD
Aktiensplits
Internet www.abmc.com
Letztes Bilanz Update 14.04.2018

Fundamentaldaten

Fundamental Verhältnisse errechnet am: 15.06.2018
KFCV KCV DIV Rendite GKR EKQ KGV KUV KBV
22,22 14,36 0,10% -17,99 21,55 -5,00 0,53 4,17

Firmenbeschreibung

American Bio Medica Corporation develops, manufactures, and sells lateral flow immunoassay tests for the immediate detection of drugs in urine and oral fluids at the point of collection. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test that detects the presence or absence of 2 to 10 drugs; Rapid ONE product line that consists of single drug tests, each of which tests for the presence or absence of a single drug; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform that detects the presence or absence of 2 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detects the presence or absence of 1 to 14 drugs, as well as private labeled versions of Rapid TOX. The company also offers OralStat, a drug test for the detection of drugs in oral fluids, as well as private labeled versions OralStat. Its tests detect various drugs, such as amphetamines, barbiturates, benzodiazepines, buprenorphine, cocaine, MDMA, methadone, methamphetamines, opiates, oxycodone, phencyclidine, propoxyphene, marijuana, and tricyclic antidepressants. In addition, the company distributes other products for the detection of substances of abuse comprising Rapid Reader, a compact, portable unit that uses a high-resolution camera to capture a picture of the results obtained when using an ABMC drug-testing product; and products that detect the presence or absence of adulterants and alcohol. Further, it provides bulk test strip contract manufacturing services to non-affiliated diagnostic companies. The company serves rehabilitation/drug treatment, pain management, other clinical, government and employment/workplace markets in the United States and internationally. The company was formerly known as American Micro Media, Inc. and changed its name to American Bio Medica Corporation in September 1992. American Bio Medica Corporation was founded in 1986 and is based in Kinderhook, New York.

Die Finanzoo GmbH übernimmt keine Haftung für die Richtigkeit der Angaben! Alle Angaben sind ohne Gewähr. Quellen: www.bundesanzeiger.de, www.sec.gov, www.abmc.com